Antimicrobial resistance in developing countries. Part II: strategies for containment
Tài liệu tham khảo
Acar, 1997, Monitoring and management of bacterial resistance to antibmicrobial agents: a World Health Organization Symposium, Geneva, Switzerland, 29th November–2nd December, 1994, Clin Infect Dis, 24, S1, 10.1093/clinids/24.Supplement_1.S1
Martin, 2004, Increased burden of illness associated with antimicrobial-resistant Salmonella enterica serotype Typhimurium infections, J Infect Dis, 189, 377, 10.1086/381270
Okeke, 2005, Antimicrobial resistance in developing countries. Part I: recent trends and current status, Lancet Infect Dis, 5, 481, 10.1016/S1473-3099(05)70189-4
Smith, 2001
Radyowijati, 2003, Improving antibiotic use in low-income countries: an overview of evidence on determinants, Soc Sci Med, 57, 733, 10.1016/S0277-9536(02)00422-7
Bauchner, 2001, Improving parent knowledge about antibiotics: a video intervention, Pediatrics, 108, 845, 10.1542/peds.108.4.845
Hennessy, 2002, Changes in antibiotic-prescribing practices and carriage of penicillin-resistant Streptococcus pneumoniae: a controlled intervention trial in rural Alaska, Clin Infect Dis, 34, 1543, 10.1086/340534
Arason, 2002, Clonal spread of resistant pneumococci despite diminished antimicrobial use, Microb Drug Resist, 8, 187, 10.1089/107662902760326896
Levy, 2001, Antibiotic resistance: consequences of inaction, Clin Infect Dis, 33, S124, 10.1086/321837
Feikin, 2000, Increased carriage of trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/pyrimethamine, J Infect Dis, 181, 1501, 10.1086/315382
Madhi, 2002, Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia, Clin Infect Dis, 35, 1120, 10.1086/343049
Duse, 1998, Antibiotic resistance in developing countries, 38
Zaidi, 2003, Risk factors for fecal quinolone-resistant Escherichia coli in Mexican children, Antimicrob Agents Chemother, 47, 1999, 10.1128/AAC.47.6.1999-2001.2003
Samore, 2001, High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission, Pediatrics, 108, 856, 10.1542/peds.108.4.856
Pelton, 2004, Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates, Pediatr Infect Dis J, 23, 1015, 10.1097/01.inf.0000143645.58215.f0
2001, 99
2002
Holloway, 2000, Prioritsing interventions to contain antimicrobial resistance, Essential Drugs Monitor, 16
Laxminarayan, 2005, Drug resistance
Nosten, 2000, Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study, Lancet, 356, 297, 10.1016/S0140-6736(00)02505-8
Kublin, 2003, Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi, J Infect Dis, 187, 1870, 10.1086/375419
Bonhoeffer, 1997, Evaluating treatment protocols to prevent antibiotic resistance, Proc Natl Acad Sci USA, 94, 12106, 10.1073/pnas.94.22.12106
Laxminarayan, 2002, On the implications of endogenous resistance to medications, J Health Econ, 21, 709, 10.1016/S0167-6296(02)00034-6
Balasubramanian, 2000, DOT or not? Direct observation of anti-tuberculosis treatment and patient outcomes, Kerala State, India, Int J Tuberc Lung Dis, 4, 409
Dye, 2002, Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis, Science, 295, 2042, 10.1126/science.1063814
Gouws, 2004, Improving antimicrobial use among health workers in first-level facilities: results from the multi-country evaluation of the Integrated Management of Childhood Illness strategy, Bull World Health Organ, 82, 509
Wammanda, 2003, Drug treatment costs: projected impact of using the integrated management of childhood illnesses, Trop Doct, 33, 86, 10.1177/004947550303300210
Bexell, 1996, Improving drug use through continuing education: a randomized controlled trial in Zambia, J Clin Epidemiol, 49, 355, 10.1016/0895-4356(95)00059-3
Santoso, 1996, Small group intervention vs formal seminar for improving appropriate drug use, Soc Sci Med, 42, 1163, 10.1016/0277-9536(95)00390-8
Agyepong, 2002, Strategies to improve adherence to recommended chloroquine treatment regimes: a quasi-experiment in the context of integrated primary health care delivery in Ghana, Soc Sci Med, 55, 2215, 10.1016/S0277-9536(01)00366-5
Qingjun, 1998, The effect of drug packaging on patients' compliance with treatment for Plasmodium vivax malaria in China, Bull World Health Organ, 76, 21
Helitzer-Allen, 1993, Malaria chemoprophylaxis compliance in pregnant women: a cost-effectiveness analysis of alternative interventions, Soc Sci Med, 36, 403, 10.1016/0277-9536(93)90402-P
Paredes, 1996, Factors influencing physicians' prescribing behaviour in the treatment of childhood diarrhoea: knowledge may not be the clue, Soc Sci Med, 42, 1141, 10.1016/0277-9536(95)00387-8
Kurlat, 1998, Infection control strategies in a neonatal intensive care unit in Argentina, J Hosp Infect, 40, 149, 10.1016/S0195-6701(98)90094-9
Klugman, 2001, Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance, Lancet Infect Dis, 1, 85, 10.1016/S1473-3099(01)00063-9
Whitney, 2003, Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine, N Engl J Med, 348, 1737, 10.1056/NEJMoa022823
Huebner, 2000, Trends in antimicrobial resistance and serotype distribution of blood and cerebrospinal fluid isolates of Streptococcus pneumoniae in South Africa, 1991–1998, Int J Infect Dis, 4, 214, 10.1016/S1201-9712(00)90112-7
Feikin, 2003, Antibiotic resistance and serotype distribution of Streptococcus pneumoniae colonizing rural Malawian children, Pediatr Infect Dis J, 22, 564, 10.1097/01.inf.0000069787.33960.d6
Zhao, 2003, Serotype distribution and antimicrobial resistance patterns in Streptococcus pneumoniae isolates from hospitalized pediatric patients with respiratory infections in Shanghai, China, Pediatr Infect Dis J, 22, 739, 10.1097/01.inf.0000078373.54515.40
Saha, 2003, Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: implications for treatment policy and vaccine formulation, J Clin Microbiol, 41, 5582, 10.1128/JCM.41.12.5582-5587.2003
Birmingham, 1997, A household survey of dysentery in Burundi: implications for the current pandemic in sub-Saharan Africa, Bull World Health Organ, 75, 45
Curtis, 2003, Effect of washing hands with soap on diarrhoea risk in the community: a systematic review, Lancet Infect Dis, 3, 275, 10.1016/S1473-3099(03)00606-6
Oddy, 2002, The impact of breastmilk on infant and child health, Breastfeed Rev, 10, 5
Khann, 2001, Cost of nosocomial infection in Turkey: an estimate based on universal hospital data, Health Services Management Research, 14, 49, 10.1258/0951484011912528
Coast, 2002, Superbugs II: how should economic evaluation be conducted for interventions which aim to contain antimicrobial resistance?, Health Econ, 11, 637, 10.1002/hec.693
Wilson, 1993, Sustained improvements in hygiene behaviour amongst village women in Lombok, Indonesia, Trans R Soc Trop Med Hyg, 87, 615, 10.1016/0035-9203(93)90260-W
Lipsky, 1999, Improving the appropriateness of vancomycin use by sequential interventions, Am J Infect Control, 27, 84, 10.1016/S0196-6553(99)70086-6
Perez, 2003, An interrupted time series analysis of parenteral antibiotic use in Colombia, J Clin Epidemiol, 56, 1013, 10.1016/S0895-4356(03)00163-X
de Vries, 1995, Impact of a short course in pharmacotherapy for undergraduate medical students: an international randomised controlled study, Lancet, 346, 1454, 10.1016/S0140-6736(95)92472-8
Bhutta, 1997, Treating dysentery with metronidazole in Pakistan, BMJ, 314, 146, 10.1136/bmj.314.7074.146a
Hadiyono, 1996, Interactional group discussion: results of a controlled trial using a behavioral intervention to reduce the use of injections in public health facilities, Soc Sci Med, 42, 1177, 10.1016/0277-9536(95)00391-6
2001
Gutierrez, 1994, Changing physician prescribing patterns: evaluation of an educational strategy for acute diarrhea in Mexico City, Med Care, 32, 436, 10.1097/00005650-199405000-00003
Perez-Cuevas, 1996, Improving physician prescribing patterns to treat rhinopharyngitis. Intervention strategies in two health systems of Mexico, Soc Sci Med, 42, 1185, 10.1016/0277-9536(95)00398-3
Thamlikitkul, 1998, Impact of an educational program on antibiotic use in a tertiary care hospital in a developing country, J Clin Epidemiol, 51, 773, 10.1016/S0895-4356(98)00059-6
Chuc, 2002, Improving private pharmacy practice: a multi-intervention experiment in Hanoi, Vietnam, J Clin Epidemiol, 55, 1148, 10.1016/S0895-4356(02)00458-4
Meyer, 2001, Randomized, controlled trial of prescribing training in a South African province, Med Educ, 35, 833, 10.1046/j.1365-2923.2001.01000.x
Chakraborty, 2000, Improving private practitioner care of sick children: testing new approaches in rural Bihar, Health Policy Plan, 15, 400, 10.1093/heapol/15.4.400
Hogerzeil, 1999, 3
Ofori-Adjei, 1996, Effect of training on the clinical management of malaria by medical assistants in Ghana, Soc Sci Med, 42, 1169, 10.1016/0277-9536(95)00389-4
Le Grand, 1999, Intervention research in rational use of drugs: a review, Health Policy Plan, 14, 89, 10.1093/heapol/14.2.89
Ande, 2004, Comparison of knowledge on diarrheal disease management between two types of community-based distributors in Oyo State, Nigeria, Health Educ Res, 19, 110, 10.1093/her/cyg004
Djimde, 1998, Use of antimalarial drugs in Mali: policy versus reality, Am J Trop Med Hyg, 59, 376, 10.4269/ajtmh.1998.59.376
Garcia, 2003, STD trends and patterns of treatment for STD by physicians in private practice in Peru, Sex Transm Infect, 79, 403, 10.1136/sti.79.5.403
Indalo, 1997, Antibiotic sale behaviour in Nairobi: a contributing factor to antimicrobial drug resistance, East Afr Med J, 74, 171
Lansang, 1990, Purchase of antibiotics without prescription on Manila, the Phillipines, J Clin Epidemiol, 43, 61, 10.1016/0895-4356(90)90057-V
Igun, 1994, Reported and actual prescription of oral rehydration therapy for childhood diarrhoeas by retail pharmacists in Nigeria, Soc Sci Med, 39, 797, 10.1016/0277-9536(94)90041-8
Massele, 1993, Knowledge and management of malaria in Dar es Salaam, Tanzania, East Afr Med J, 70, 639
Larsson, 2000, Antibiotic medication and bacterial resistance to antibiotics: a survey of children in a Vietnamese community, Trop Med Int Health, 5, 711, 10.1046/j.1365-3156.2000.00630.x
Uppal, 1994, Pharmacoepidemiology of drug use at two primary health care centres in northern India, Int J Clin Pharmacol Ther, 32, 284
Dua, 1994, The use of antimicrobial drugs in Nagpur, India. A window on medical care in a developing country, Soc Sci Med, 38, 717, 10.1016/0277-9536(94)90462-6
Bartoloni, 1998, Patterns of antimicrobial use and antimicrobial resistance among healthy children in Bolivia, Trop Med Int Health, 3, 116, 10.1046/j.1365-3156.1998.00201.x
Chalker, 2002, Private pharmacies in Hanoi, Vietnam: a randomized trial of a 2-year multi-component intervention on knowledge and stated practice regarding ARI, STD and antibiotic/steroid requests, Trop Med Int Health, 7, 803, 10.1046/j.1365-3156.2002.00934.x
Ross-Degnan, 1996, The impact of face-to-face educational outreach on diarrhoea treatment in pharmacies, Health Policy Plan, 11, 308, 10.1093/heapol/11.3.308
Adams, 2003, The cost-effectiveness of syndromic management in pharmacies in Lima, Peru, Sex Transm Dis, 30, 379, 10.1097/00007435-200305000-00002
Kunin, 1990, Problems in antibiotic usage, 427
Kubin, 2002, Antimicrobial control programs, Semin Perinatol, 26, 379, 10.1053/sper.2002.36271
Erbay, 2003, Evaluation of antibiotic use in a hospital with an antibiotic restriction policy, Int J Antimicrob Agents, 21, 308, 10.1016/S0924-8579(02)00392-8
Saez-Llorens, 2000, Impact of an antibiotic restriction policy on hospital expenditures and bacterial susceptibilities: a lesson from a pediatric institution in a developing country, Pediatr Infect Dis J, 19, 200, 10.1097/00006454-200003000-00005
Gove, 1997, Integrated management of childhood illness by outpatient health workers: technical basis and overview. The WHO working group on guidelines for integrated management of the sick child, Bull World Health Organ, 75, 7
Phillips-Howard, 2003, Diagnostic and prescribing practices in peripheral health facilities in rural western Kenya, Am J Trop Med Hyg, 68, 44, 10.4269/ajtmh.2003.68.44
Oluwole, 2000, Management of childhood illness in Africa. Early evaluations show promising results, BMJ, 320, 594, 10.1136/bmj.320.7235.594
Khan, 2002, Adopting integrated management of childhood illness module at local level in Bangladesh: implications for recurrent costs, J Health Popul Nutr, 20, 42
Boulanger, 1999, Treatment in Kenyan rural health facilities: projected drug costs using the WHO-UNICEF integrated management of childhood illness (IMCI) guidelines, Bull World Health Organ, 77, 852
Armstrong Schellenberg, 2004, The effect of Integrated Management of Childhood Illness on observed quality of care of under-fives in rural Tanzania, Health Policy Plan, 19, 1, 10.1093/heapol/czh001
Laing, 2001, Ten recommendations to improve use of medicines in developing countries, Health Policy Plan, 16, 13, 10.1093/heapol/16.1.13
Ball, 2002, Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence, J Antimicrob Chemother, 49, 31, 10.1093/jac/49.1.31
Lan, 2003, Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum beta-lactamase-producing organisms, J Microbiol Immunol Infect, 36, 182
Garau, 2001, Have guidelines had an impact on antimicrobial resistance?, Semin Respir Infect, 16, 210, 10.1053/srin.2001.25627
Thamlikitkul, 2004, Implementation of clinical practice guidelines for upper respiratory infection in Thailand, Int J Infect Dis, 8, 47, 10.1016/j.ijid.2003.09.001
Angunawela, 1991, Experimental evaluation of the effects of drug information on antibiotic prescribing: a study in outpatient care in an area of Sri Lanka, Int J Epidemiol, 20, 558, 10.1093/ije/20.2.558
Fasehun, 1999, The antibacterial paradox: essential drugs, effectiveness, and cost, Bull World Health Organ, 77, 211
2002
Lindtjorn, 1987, Essential drug list in a rural hospital. Does it have any influence on drug prescription?, Trop Doct, 17, 151, 10.1177/004947558701700404
Mabadeje, 1991, The value and effects of implementing an essential drugs list in the Lagos University Teaching Hospital, Clin Pharmacol Ther, 50, 121, 10.1038/clpt.1991.114
Pechere, 2001, Patients' interviews and misuse of antibiotics, Clin Infect Dis, 33, S170, 10.1086/321844
Goff, 2002, Obtaining antibiotics without a prescription, N Engl J Med, 347, 223, 10.1056/NEJM200207183470319
Carey, 2003, Antibiotic misuse in the community—a contributor to resistance?, Ir Med J, 96, 43
Edwards, 2002, Parental use and misuse of antibiotics: are there differences in urban vs. suburban settings?, Acad Emerg Med, 9, 22, 10.1111/j.1553-2712.2002.tb01162.x
Reyes, 1997, Antibiotic noncompliance and waste in upper respiratory infections and acute diarrhea, J Clin Epidemiol, 50, 1297, 10.1016/S0895-4356(97)00197-2
Guyon, 1994, A baseline survey on the use of drugs at the primary health care level in Bangladesh, Bull World Health Organ, 72, 265
Dutta, 2001, Blister pack ingestion resulting in esophago-pleural fistula, Indian J Gastroenterol, 20, 79
Kansal, 2000, Intestinal perforation—a unique cause, J Indian Med Assoc, 98, 184
Yip, 1998, “I've got a UFO stuck in my throat!”—an interesting case of foreign body impaction in the oesophagus, Singapore Med J, 39, 121
Chan, 1997, “Blister pack”-induced gastrointestinal hemorrhage, Am J Gastroenterol, 92, 172
1999, Prospective multicentre hospital surveillance of Streptococcus pneumoniae disease in India, Lancet, 353, 1216, 10.1016/S0140-6736(98)07228-6
Davidson, 1998, A controlled comparison of directly observed therapy vs self-administered therapy for active tuberculosis in the urban United States, Chest, 114, 1239, 10.1378/chest.114.5.1239
Dye, 2002, Low access to a highly effective therapy: a challenge for international tuberculosis control, Bull World Health Organ, 80, 437
Floyd, 1997, Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa, BMJ, 315, 1407, 10.1136/bmj.315.7120.1407
Xu, 2000, Cost effectiveness of DOTS and non-DOTS strategies for smear-positive pulmonary tuberculosis in Beijing, Biomed Environ Sci, 13, 307
Khatri, 2002, Rapid DOTS expansion in India, Bull World Health Organ, 80, 457
2004
Wilkinson, 1997, Coping with Africa's increasing tuberculosis burden: are community supervisors an essential component of the DOT strategy? Directly observed therapy, Trop Med Int Health, 2, 700, 10.1046/j.1365-3156.1997.d01-358.x
Barker, 2002, Unpaid community volunteers–effective providers of directly observed therapy (DOT) in rural South Africa, S Afr Med J, 92, 291
Pungrassami, 2002, Are health personnel the best choice for directly observed treatment in southern Thailand? A comparison of treatment outcomes among different types of observers, Trans R Soc Trop Med Hyg, 96, 695, 10.1016/S0035-9203(02)90354-8
Olle-Goig, 2001, Treatment of tuberculosis in a rural area of Haiti: directly observed and non-observed regimens. The experience of H pital Albert Schweitzer, Int J Tuberc Lung Dis, 5, 137
Gupta, 2001
Arnadottir, 2001, Tuberculosis: trends and the twenty-first century, Scand J Infect Dis, 33, 563, 10.1080/00365540110026836
DeRiemer, 2005, Does DOTS work in populations with drug-resistant tuberculosis?, Lancet, 365, 1239, 10.1016/S0140-6736(05)74812-1
Friedland, 2004, Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries, Clin Infect Dis, 38, S421, 10.1086/421407
Wayland, 2004, The failure of pharmaceuticals and the power of plants: medicinal discourse as a critique of modernity in the Amazon, Soc Sci Med, 58, 2409, 10.1016/j.socscimed.2003.09.023
Harbarth, 2003, Shortage of penicillin G: impact on antibiotic prescribing at a US tertiary care centre, Int J Antimicrob Agents, 21, 484, 10.1016/S0924-8579(03)00003-7
Gupta, 2001, Public health. Responding to market failures in tuberculosis control, Science, 293, 1049, 10.1126/science.1061861
Gupta, 2004, Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis, Lancet, 363, 320, 10.1016/S0140-6736(03)15394-9
Okeke, 1999, Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries, Emerg Infect Dis, 5, 18, 10.3201/eid0501.990103
Salako, 2001, Treatment of childhood fevers and other illnesses in three rural Nigerian communities, J Trop Pediatr, 47, 230, 10.1093/tropej/47.4.230
Brieger, 2004, Interactions between patent medicine vendors and customers in urban and rural Nigeria, Health Policy Plan, 19, 177, 10.1093/heapol/czh021
Primo-Carpenter, 2004, 50
Nizami, 1996, Drug prescribing practices of general practitioners and paediatricians for childhood diarrhoea in Karachi, Pakistan, Soc Sci Med, 42, 1133, 10.1016/0277-9536(95)00386-X
Bojalil, 1994, Antibiotic misuse in diarrhea. A household survey in a Mexican community, J Clin Epidemiol, 47, 147, 10.1016/0895-4356(94)90019-1
O'Connor, 2001, Physician control of pediatric antimicrobial use in Beijing, China, and its rural environs, Pediatr Infect Dis J, 20, 679, 10.1097/00006454-200107000-00008
Chuc, 1999, “Doi moi” and private pharmacies: a case study on dispensing and financial issues in Hanoi, Vietnam, Eur J Clin Pharmacol, 55, 325, 10.1007/s002280050636
Mberu, 2000, The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya, Am J Trop Med Hyg, 62, 396, 10.4269/ajtmh.2000.62.396
Terlouw, 2003, Sulfadoxine-pyrimethamine in treatment of malaria in western Kenya: increasing resistance and underdosing, Antimicrob Agents Chemother, 47, 2929, 10.1128/AAC.47.9.2929-2932.2003
Sibley, 2001, Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?, Trends Parasitol, 17, 582, 10.1016/S1471-4922(01)02085-2
Liu, 1999, Extent of antibiotic use in Taiwan shown by antimicrobial activity in urine, Lancet, 354, 1360, 10.1016/S0140-6736(99)07446-2
Liu, 2001, Inappropriate use of antibiotics and the risk for delayed admission and masked diagnosis of infectious diseases: a lesson from Taiwan, Arch Intern Med, 161, 2366, 10.1001/archinte.161.19.2366
Parimi, 2002, The general public's perceptions and use of antimicrobials in Trinidad and Tobago, Rev Panam Salud Publica, 12, 11, 10.1590/S1020-49892002000700003
Okeke, 2003, Export of antimicrobial drugs by West African travelers, J Travel Med, 10, 133, 10.2310/7060.2003.31786
Bi, 2000, Family self-medication and antibiotics abuse for children and juveniles in a Chinese city, Soc Sci Med, 50, 1445, 10.1016/S0277-9536(99)00304-4
Crabbe, 1996, Why do men with urethritis in Cameroon prefer to seek care in the informal health sector?, Genitourin Med, 72, 220
Okeke, 2003, Antibiotic use and resistance in developing countries, 132
Marin, 1995, A research agenda for health education among underserved populations, Health Educ Q, 22, 346, 10.1177/109019819402200307
Gonzalez Ochoa, 1996, Prescription of antibiotics for mild acute respiratory infections in children, Bull Pan Am Health Organ, 30, 106
Denis, 1998, Improving compliance with quinine + tetracycline for treatment of malaria: evaluation of health education interventions in Cambodian villages, Bull World Health Organ, 76, 43
Bavestrello, 2002, Impact of regulatory measures in the trends of community consumption of antibiotics in Chile, Rev Med Chil, 130, 1265, 10.4067/S0034-98872002001100009
Bhutta, 1996, Assessing the impact of a regulatory intervention in Pakistan, Soc Sci Med, 42, 1195, 10.1016/0277-9536(95)00392-4
Bavestrello, 2000, How Chile tackled overuse of antimicrobials, Essential Drugs Monitor, 13
Forder, 1995, How best to utilize limited resources, J Hosp Infect, 30, 15, 10.1016/0195-6701(95)90002-0
Folb, 1994
1992
Wondemagegnehu, 1999
Okeke, 1995, Quality and bioavailability of tetracycline capsules in a Nigerian semi-urban community, Int J Antimicrob Agents, 5, 245, 10.1016/0924-8579(94)00064-2
Shakoor, 1997, Assessment of the incidence of substandard drugs in developing countries, Trop Med Int Health, 2, 839, 10.1046/j.1365-3156.1997.d01-403.x
Taylor, 2001, Pharmacopoeial quality of drugs supplied by Nigerian pharmacies, Lancet, 357, 1933, 10.1016/S0140-6736(00)05065-0
Okeke, 2001, Quality and bioavailability of ampicillin capsules dispensed in a Nigerian semi-urban community, Afr J Med Med Sci, 30, 47
Arya, 2002, Global response to antimicrobial resistance, Bull World Health Organ, 80, 420
Schrag, 2001, Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial, JAMA, 286, 49, 10.1001/jama.286.1.49
Berkley, 2001, Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa, Lancet, 357, 1753, 10.1016/S0140-6736(00)04897-2
Rashid, 1986, Pattern of antibiotic use in two teaching hospitals, Trop Doct, 16, 152, 10.1177/004947558601600405
Lim, 1992, Bacteriology turnaround time in seven Malaysian general hospitals, Malays J Pathol, 14, 41
Shapiro, 2001, Antimicrobial-resistant bacterial diarrhea in rural western Kenya, J Infect Dis, 183, 1701, 10.1086/320710
Halstead, 2004, Reality of developing a community-wide antibiogram, J Clin Microbiol, 42, 1, 10.1128/JCM.42.1.1-6.2004
Williams, 1998, Surveillance of antimicrobial resistance—an international perspective, BMJ, 317, 651, 10.1136/bmj.317.7159.651
Mutanda, 1989, Adaptation of a method of measuring zone diameters of bacterial growth inhibition by antibiotics to suit developing countries, East Afr Med J, 66, 441
O'Brien, 1996, WHONET: removing obstacles to the full use of information about antibiotic resistance, Diag Microbiol Infect Dis, 25, 163, 10.1016/S0732-8893(96)00139-3
Seppala, 1997, The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland, N Engl J Med, 337, 441, 10.1056/NEJM199708143370701
Aarestrup, 2001, Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark, Antimicrob Agents Chemother, 45, 2054, 10.1128/AAC.45.7.2054-2059.2001
Holloway K, Sorensen T, WHO pilot projects to contain antimicrobial resistance. Second International Conference on Improving Use of Medicines; March 30–April 2, 2004; Chiang Mai, Thailand
Enne, 2001, Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction, Lancet, 357, 1325, 10.1016/S0140-6736(00)04519-0
Anderson, 1991
Liu, 1995, Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China, Bull World Health Organ, 73, 483
Cortese, 2002, Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America, J Infect Dis, 186, 999, 10.1086/342946
Tapsall, 2001
Bergstrom, 2004, Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals, Proc Natl Acad Sci USA, 101, 13285, 10.1073/pnas.0402298101
Levin, 2004, Cycling antibiotics may not be good for your health, Proc Natl Acad Sci USA, 101, 13101, 10.1073/pnas.0404970101
Palumbi, 2001, Humans as the world's greatest evolutionary force, Science, 293, 1786, 10.1126/science.293.5536.1786
Huovinen, 1995, Trimethoprim and sulfonamide resistance, Antimicrob Agents Chemother, 39, 279, 10.1128/AAC.39.2.279
Wilton, 2002, Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and cost-effectiveness, J Health Serv Res Policy, 7, 111, 10.1258/1355819021927764
Green, 2003, Antimicrobial resistance containment strategies of the rational pharmaceutical management program, 215
Richet, 2001, Building communication networks: international network for the study and prevention of emerging antimicrobial resistance, Emerg Infect Dis, 7, 319, 10.3201/eid0702.010235